The 16th International Conference on Human Antibodies & Hybridomas (HAH 2011) November 6, 2011

The HAH 2011 scientific program will include keynote lectures, contributed papers and poster presentations emphasizing all key aspects of human antibody and hybridoma technology, applications and engineering. HAH 2011 will be placing special emphasis on and devoting at least one day of the 2011 conference to presentations covering Therapeutic Antibodies to include:
• Preclinical Issues
• Manufacturing/Stabilization
• Clinical Issues
• Regulatory and IP Issues

Fabrizio Giannotta will present “Epitope mapping and key amino acid identification of anti-CD22 immunotoxin CAT-8015 using hybrid betalactamase display.”